Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 34 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07197762
- Conditions
- Neisseria Meningitidis
- Locations
-
- Emory Children's Center-Vaccine Research Clinic Atlanta, Georgia, United States
- Hope Clinic Atlanta, Georgia, United States
Not Yet Recruiting
Metagenomic Analysis of the Pharynx in High Risk Partners
NCT07671014
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +20 more
- Locations
-
Not specified
NCT01621945
- Conditions
- Neisseria Meningitidis
- Locations
-
- Maison Du Département Neufchâtel-en-Bray, France
Completed
Study to Assess Oropharyngeal Carriage of N. Meningitidis in South Australian School Leavers
NCT03419533
- Conditions
- Neisseria Meningitidis
- Locations
-
- Women's and Children's Hosptial Adelaide, South Australia, Australia
NCT02398396
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Factor H-binding Protein, Neisseria Meningitidi, +6 more
- Locations
-
- Centre for Clinical Vaccinology and Tropical Medicine (CCVTM) Oxford, Oxfordshire, United Kingdom
NCT00454987
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
- Locations
-
- GSK Investigational Site Bydgoszcz, Poland
- GSK Investigational Site Gdansk, Poland
- GSK Investigational Site Kielce, Poland
- GSK Investigational Site Krakow, Poland
Completed
Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)
NCT01553279
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Infections, +2 more
- Locations
-
Not specified
NCT01839188
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Infections, +2 more
- Locations
-
Not specified
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Fayetteville, Arkansas, United States
- GSK Investigational Site Jonesboro, Arkansas, United States
- GSK Investigational Site Fresno, California, United States
NCT00129116
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Asse, Belgium
- GSK Investigational Site Drongen, Belgium
- GSK Investigational Site Ghent, Belgium
- GSK Investigational Site Maldegem, Belgium
NCT00127855
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site North Adelaide, South Australia, Australia
- GSK Investigational Site Carlton, Victoria, Australia
- GSK Investigational Site Subiaco, Western Australia, Australia
NCT00586612
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Barcelona, Spain
- GSK Investigational Site Bilbao, Spain
- GSK Investigational Site Burgos, Spain
- GSK Investigational Site Getafe, Spain
NCT00326118
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Garran, Australian Capital Territory, Australia
- GSK Investigational Site Randwick, New South Wales, Australia
- GSK Investigational Site Westmead, New South Wales, Australia
- GSK Investigational Site Herston, Queensland, Australia
NCT00129129
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Fountain Valley, California, United States
- GSK Investigational Site Centennial, Colorado, United States
- GSK Investigational Site Norwich, Connecticut, United States
Completed
Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine
NCT00289783
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Bryant, Arkansas, United States
NCT00197795
- Conditions
- Neisseria Meningitidis
- Locations
-
Not specified
NCT01090453
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
- Locations
-
- GSK Investigational Site Vancouver, British Columbia, Canada
- GSK Investigational Site Winnipeg, Manitoba, Canada
- GSK Investigational Site Hamilton, Ontario, Canada
- GSK Investigational Site Aix-en-Provence, France
Completed
Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines
NCT00134719
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site North Adelaide, South Australia, Australia
- GSK Investigational Site Carlton, Victoria, Australia
- GSK Investigational Site Perth, Western Australia, Australia
NCT00871338
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Ely, Cambridgeshire, United Kingdom
- GSK Investigational Site Southampton, Hampshire, United Kingdom
- GSK Investigational Site Oxford, Oxfordshire, United Kingdom
- GSK Investigational Site Bristol, United Kingdom
NCT00891176
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany
- GSK Investigational Site Bretten, Baden-Wurttemberg, Germany
- GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
- GSK Investigational Site Karlsruhe, Baden-Wurttemberg, Germany